Pengfei Lin
- Clinical Biochemistry top 5%
- Immunology and Allergy top 5%
-
- Hereditary Neurological Disorders 10
- Genetic Neurodegenerative Diseases 10
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 7
-
- Muscle Physiology and Disorders 12
- Mitochondrial Function and Pathology 10
- RNA Research and Splicing 8
-
- Neurogenetic and Muscular Disorders Research 10
-
- Cardiomyopathy and Myosin Studies 9
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Pengfei Lin
60 papers receiving 865 citations
Peers
Comparison fields: 5 of 90
- Clinical Biochemistry 124
- Immunology and Allergy 92
- Cancer Research 142
- Cellular and Molecular Neuroscience 169
- Neurology 64
Countries citing papers authored by Pengfei Lin
This map shows the geographic impact of Pengfei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Lin more than expected).
Fields of papers citing papers by Pengfei Lin
This network shows the impact of papers produced by Pengfei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Lin. The network helps show where Pengfei Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengfei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 45 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 0 | |
| 11 | 2020 | 34 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 13 | |
| 14 | 2016 | 6 | |
| 15 | The role of TAK1 expression in thyroid cancer. | 2015 | 11 |
| 16 | 2015 | 35 | |
| 17 | 2014 | 12 | |
| 18 | 2014 | 43 | |
| 19 | 2012 | 19 | |
| 20 | Experiment on Production in Vitro of Porcine Somatic Cell Cloned Embryos | 2009 | 1 |
About Pengfei Lin
Pengfei Lin is a scholar working on Cellular and Molecular Neuroscience, Genetics and Immunology and Allergy, having authored 66 papers that have together received 872 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (12 papers), Mitochondrial Function and Pathology (10 papers), Hereditary Neurological Disorders (10 papers), Genetic Neurodegenerative Diseases (10 papers), Neurogenetic and Muscular Disorders Research (10 papers), Cardiomyopathy and Myosin Studies (9 papers), RNA Research and Splicing (8 papers) and Amyotrophic Lateral Sclerosis Research (7 papers). The work is most often cited by research in Clinical Biochemistry (124 citations), Immunology and Allergy (92 citations) and Cancer Research (142 citations). Pengfei Lin has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chuanzhu Yan, Yuying Zhao, Yaoqin Gong, Bing Wen, Kunqian Ji, Weibo Niu, Jiayong Wang, Jun Niu, Huijie Gao and Enyu Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.